Who owns Essa Pharma Inc?
- Ticker: EPIX
- CUSIP Number: 29668h708
Tip: Access positions for across all investors
Analyze quarterly positions in Essa Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Essa Pharma stock
Who bought or sold Essa Pharma Inc this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
---|---|---|---|---|---|
BVF | 8.7M | $16M | 0% | Dec 2024 |
|
Tang Capital Management | 4.3M | $7.7M | 100% | Dec 2024 |
|
BML Capital Management | 4.2M | $7.6M | 100% | Dec 2024 |
|
Morgan Stanley | 4.2M | $7.5M | 0% | Dec 2024 |
|
Soleus Capital Management | 2.3M | $4.0M | -47% | Dec 2024 |
|
Opaleye Management | 2.2M | $4.0M | 100% | Dec 2024 |
|
Altium Capital Management | 1.4M | $2.6M | 100% | Dec 2024 |
|
Rtw Investments | 1.1M | $2.0M | -66% | Dec 2024 |
|
Bank of America Corporation | 812k | $1.5M | 10153775% | Dec 2024 |
|
Aldebaran Capital | 398k | $712k | 100% | Dec 2024 |
|
Two Sigma Investments | 211k | $378k | 100% | Dec 2024 |
|
Citadel Advisors | 198k | $355k | 295% | Dec 2024 |
|
Marshall Wace | 181k | $324k | 100% | Dec 2024 |
|
Bnp Paribas Arbitrage, Snc | 165k | $295k | 270% | Dec 2024 |
|
UBS Group | 96k | $171k | 3856% | Dec 2024 |
|
Two Sigma Advisers | 83k | $148k | 100% | Dec 2024 |
|
Magnus Financial Group | 55k | $87k | 0% | Mar 2025 |
|
Vazirani Asset Management | 50k | $90k | 100% | Dec 2024 |
|
Schonfeld Strategic Advisors | 49k | $87k | -82% | Dec 2024 |
|
American Century Companies | 46k | $83k | -1% | Dec 2024 |
|
Jane Street | 46k | $82k | 100% | Dec 2024 |
|
XTX Topco | 38k | $67k | 100% | Dec 2024 |
|
Group One Trading | 36k | $65k | 31% | Dec 2024 |
|
Geode Capital Management | 27k | $48k | 0% | Dec 2024 |
|
Cubist Systematic Strategies | 26k | $47k | 100% | Dec 2024 |
|
Springbok Capital Management | 25k | $45k | 100% | Dec 2024 |
|
Susquehanna International | 18k | $32k | 17% | Dec 2024 |
|
Gts Securities | 17k | $30k | 100% | Dec 2024 |
|
Two Sigma Securities | 16k | $29k | 100% | Dec 2024 |
|
Acadian Asset Management | 16k | $28k | 100% | Dec 2024 |
|
Squarepoint Ops | 15k | $26k | 100% | Dec 2024 |
|
49 Wealth Management | 11k | $20k | 100% | Dec 2024 |
|
BlackRock | 7.1k | $13k | 26% | Dec 2024 |
|
Advisor Group Holdings | 6.0k | $36k | 0% | Dec 2024 |
|
Federation des caisses Desjardins du Quebec | 4.1k | $7.2k | 0% | Dec 2024 |
|
Truvestments Capital | 3.9k | $7.1k | 366% | Dec 2024 |
|
Atlantic Trust | 2.5k | $4.6k | 0% | Dec 2024 |
|
Royal Bank of Canada | 918.00 | $0 | -98% | Dec 2024 |
|
TD Waterhouse Canada | 900.00 | $1.6k | 0% | Dec 2024 |
|
Laurel Wealth Advisors | 600.00 | $948.000000 | 0% | Mar 2025 |
|
Barclays | 355.00 | $999.999500 | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 21.00 | $37.999500 | 0% | Dec 2024 |
|
Who sold out of Essa Pharma?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
---|---|---|---|
Bellevue Group | Sep 2024 | 7.9M | $48M |
Partner Fund Management | Sep 2024 | 2.7M | $17M |
Adage Capital Partners GP | Sep 2024 | 1.5M | $8.9M |
Rhenman & Partners Asset Management AB | Sep 2024 | 805k | $4.9M |
Rock Springs Capital Management | Sep 2024 | 677k | $4.1M |
Parkman Healthcare Partners | Sep 2024 | 346k | $2.1M |
CIBC World Markets | Sep 2024 | 74k | $446k |
D. E. Shaw & Co | Sep 2024 | 63k | $382k |
Kennedy Capital Management | Sep 2024 | 41k | $249k |
FNY Investment Advisers | Dec 2024 | 25k | $44k |
Simplex Trading | Sep 2024 | 5.2k | $31k |